No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
Pfizer’s Adalimumab Biosimilar PBS-listed in Australia
On 1 August 2024, the PBS published its Summary of Changes, which included listing Pfizer’s Abrilada®, biosimilar to AbbVie’s Humira® (adalimumab), on the PBS in 20mg/0.4mL and 40mg/0.8mL dosage injections. This comes three years after Abrilada was first recommended...